Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C | Zendy

Juan Macı́as | Zendy; Karin Neukam | Zendy; Joaquín Portilla | Zendy; J. A. Iribarren | Zendy; Ignacio de los Santos | Zendy; Antonio Rivero | Zendy; Manuel Márquez | Zendy; Marcial Delgado | Zendy; Francisco Téllez | Zendy; Dolores Merino | Zendy; Livia Giner | Zendy; M. A. von Wichmann | Zendy; Juan A. Pineda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C

Author(s) -

Juan Macı́as,

Karin Neukam,

Joaquín Portilla,

J. A. Iribarren,

Ignacio de los Santos,

Antonio Rivero,

Manuel Márquez,

Marcial Delgado,

Francisco Téllez,

Dolores Merino,

Livia Giner,

M. A. von Wichmann,

Juan A. Pineda

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkr083

Subject(s) - raltegravir , medicine , gastroenterology , cirrhosis , viral load , hepatitis c , incidence (geometry) , hepatitis c virus , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , virus , physics , optics

To evaluate the liver safety of raltegravir-including combinations in HIV/hepatitis C virus (HCV) co-infected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore